Givlaari safe, effective for acute hepatic porphyria patients: Study
Givlaari reduced porphyria attacks, improved quality of life in patients with AHP, according to an expanded access program in Japan.| Porphyria News
Givlaari reduced porphyria attacks, improved quality of life in patients with AHP, according to an expanded access program in Japan.| Porphyria News
Andrea Lobo is a science writer for Porphyria News with a PhD in cell biology/neurosciences. She covers the latest news and information on a variety of porphyria topics.| Porphyria News
